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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S277destruction was particularly found at the lateral plateau (48% lower).
Interestingly, ASC-treatment had a protective effect on new cartilage and
bone formation in the ligaments. At day 42, the surface percentage of the
cruciate ligament which stained positive for proteoglycan deposition was
decreased by nearly 43% in the ASC treated joints when compared to
controls. In line with that, osteophyte formation in the medial collateral
ligament was signiﬁcantly reduced by 91% in ASC-treated animals
compared to control. In contrast to early treatment, injection of the same
dose of ASCs, 14 days after induction of OA only showed a small inhibiting
effect on osteophyt formation and synovial activation when measured at
day 42. Although cartilage destruction diminished with 28%, these values
did not reach signiﬁcance at that time-point.
Conclusions: Our study indicates that a single injection of ASCs into the
knee joints of mice with collagenase-induced osteoarthritis prevents
cartilage damage and the formation of bone structures within the liga-
ments, probably by inhibiting activation of the synovial macrophages.
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CHONDROGENIC AND IMMUNOPHENOTYPIC PROPERTIES OF
MESENCHYMAL STEM CELLS FROM OSTEOARTHRITIS PATIENTS
S. Hagmann, B. Moradi, S. Frank, A.-M. Bäsig, T. Dreher, W. Richter,
T. Gotterbarm. Dept. of Orthopedics and Traumatology, Heidelberg, Germany
Purpose:Mesenchymal stem cells (MSCs) are a promising target for future
cell-based therapies in osteoarthritis. In this context, cartilage tissue
engineering is a major ﬁeld of research, with effective cartilage repair
being the ultimate objective. There is a controversy whether osteoarthritis
and age affect the regenerative potential of MSCs. Also, in the last decade, it
has become clear that MSCs are heterogeneous populations not only
regarding their regenerative potential, but also regarding their surface
markers. The aim of this study was to analyse the inﬂuence of osteoar-
thritis and age on growth parameters, immunophenotype and chondro-
genic differentiation potential of human bone marrow derived MSCs.
Methods:MSCs were isolated from bone marrow of osteoarthritis patients
(n¼5, OA) and patients without clinical and radiological signs of osteoar-
thritis (n¼5, non-OA) and expanded in different cell culture media. Flow
cytometry analysis was performed for CD10, CD13, CD14, CD34, CD44,
CD45, CD49, CD73, CD90, CD105, CD117, CD133, CD 140b, CD 166, CD271,
CD340, Stro-1 and HLA-ABC. Chondrogenic differentiation was induced
with chondrogenic medium in pellet culture. Chondrogenic differentiation
potential was evaluated by a DMMB-assay and by semiquantitative anal-
ysis of GAG percentage (SafraninO/FastGreen staining). Statistical analysis
as performed with analyses of variance (ANOVA).
Results: Both in the OA and the non-OA group, MSCs were negative for
CD14, CD34 and CD45 and positive for CD13, CD44, CD73, CD90, CD105 and
CD166. CD49, CD105, CD140b, CD146, CD340 and Stro-1 showed differ-
ences depending from the media applied, but no signiﬁcant differences
were observed between the OA and non-OA group. The expression of the
MSC surface markers CD10, CD49 and CD146 showed high donor depen-
dence while for these markers there was no signiﬁcant difference between
the OA and the non-OA group. Cell proliferation differed substantiallyMonths n Suture
Load to failure (N) 1 4 1.31 [1.19-1.69]
2 4 1.22 [0.76-1.60]
3 3 1.14 [0.28-1.29]
Total n 11
Stiffness (N/mm) 1 4 1.20 [0.99-1.42]
2 4 0.86 [0.49-0.91]c
3 3 0.70 [0.37-0.90]a
Total n 11
Deformation (mm) 1 4 1.13 [0.77-1.40]
2 4 1.53 [1.13-1.75]
3 3 1.15 [0.68-1.68]
Total n 11
a Statistically signiﬁcant from same group repair.
b Statistically signiﬁcant from Suture vs MSC-Membrane
c Statistically signiﬁcant from Membrane vs MSC-Membranebetween different culture media while the growth index parameters were
similar in the OA and non-OA group. There was no difference in MSC
chondrogenic potential between OA and non OA patients while the culture
media had an important inﬂuence on chondrogenic differentiation.
Conclusions: Our ﬁndings add to the reports that negate the regenerative
inferiority of MSCs from OA affected patients. Our experiments rather
suggest that MSCs extracted from OA patients are an adequate source for
cartilage tissue engineering, which is supported by the ﬁnding that MSC
surface markers do not seem to be inﬂuenced by age or presence of OA.
Our data also reﬂects that MSCs are heterogeneous regarding some of their
surface markers and that culture conditions seem to have an important
inﬂuence on both immunophenotype and chondrogenic potential.
In the long-term, understanding the potential of MSC heterogeneity and of
culture conditions will hopefully lead to more efﬁcient cartilage tissue
engineering.
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LONG-TERM EFFICACY OF MESENCHYMAL STEM CELLS IMPLANTATION
IN COMBINATION WITH TYPE I COLLAGEN MEMBRANE: A RAT
EXPERIMENTAL MODEL OF ROTATOR CUFF TEARS.
P. Tornero-Esteban, C. Rodriguez-Bobada, J. Hoyas, E. Villafuertes,
F. Marco, B. Fernandez-Gutierrez. Hosp. Clinico San Carlos, Madrid, Spain
Purpose: The Supraspinatus tendon (SE) is an essential structure for the
proper function of the rotator cuff frequently affected in rotator cuff tears.
Common surgical procedures to repair SE lesions are usually adequate in
the short term, but they are often unsatisfactory in the long term pre-
senting a high rate of re-rupture. In this context, there is a need for new
techniques allowing a more efﬁcient repair. Regenerative medicine using
mesenchymal stem cells (MSCs) offers a promising alternative. This study
explore in a rat model the possible beneﬁts of a treatment based on MSC-
collagen membrane graft compared to conventional treatment (suture) or
collagen membrane graft.
Methods: A chronic rotator cuff tear injury model was developed by
unilaterally detaching the SE tendon of adult Sprague-Dawley rats. One
month post-injury, the tendon was repaired by: a) Classical surgery, using
single suture. b) suture + type I collagen membranes without cells;
Membrane or c) suture + type I collagen membranes + 1x106 allogeneic
MSCs; (n¼12; MSC-Membrane). Lesion was evaluated at 1 month, 2
months and three months post-injury by biomechanical criteria including
“load-to-failure” measured (Newtons), Stifness (N/mm) and deformation
(mm). The opposing and not injured shoulder was used as positive control
after normalization. Non-parametric Mann-Whitney U test was used for
statistical analysis, p < 0.05 was considered signiﬁcant.
Results: Biomechanical properties (median [25%-75% percentil]) of tendon
repair
Conclusions: We observed that implanting MSC-Membrane into surgi-
cally created tendon defects improved the strength and stiffness of the
repaired tendon at three months, indicating that the reparation process
ameliorated after long-term. This likely indicates that long-term efﬁcacy
is inﬂuenced by underlying mechanism improving the natural tendon
repair.n Membrane n MSC-Membrane
6 0.73 [0.35-1.23] 6 1.04 [0.77-1.22]b
4 0.99 [0.63-1.59] 5 1.11 [0.74-1.39]
5 0.94 [0.84-1.27] 4 1.70 [1.27-1.79]a,b,c
15 15
6 0.62 [0.44-0.88] 6 0.63 [0.46-0.90]
4 0.87 [0.53-2.15] 5 0.66 [0.47-1.05]
5 0.91 [0.60-2.03] 4 1.16 [1.04-1.32] a,b
15 15
6 1.12 [0.84-1.66] 6 1.21 [0.83-2.02]
4 1.01 [0.82-1.65] 5 0.98 [0.84-1.92]
5 1.32 [0.54-2.30] 4 1.30 [0.84-1.42]
15 15
